HCA Healthcare, Inc.
HCA · Healthcare · · USDFahodi Score HOLD Mid-term (Position)
58
/ 100
Technical
60
Trend & RS
75
Momentum
83
Fundamental
33
Macro
22
Liquidity
61
| Component | Score | Weight |
|---|---|---|
| Technical | 60.0 | 20% |
| Trend & RS | 75.1 | 30% |
| Momentum | 82.6 | 15% |
| Fundamental | 33.3 | 10% |
| Macro | 22.5 | 20% |
| Liquidity | 61.1 | 5% |
Trade Setup
| Entry | 507.48 |
| Stop Loss | 472.62 (6.9%) |
| Target 1 (1:1) | 542.34 (+6.9%) |
| Target 2 (2:1) | 577.20 (+13.7%) |
| ATR(14) | 17.43 (3.4%) |
| Risk per Share | 34.86 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 73.7 | +0.95 | |
| Momentum | 82.6 | +1.30 | |
| Quality | 23.2 | -1.07 | |
| Composite | 59.8 | ||
Quality Scores
Piotroski F-Score
3
/9 —
Weak
✓
✗
✗
✗
✗
✗
✓
✓
✗
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
Insufficient Data
Valuation vs Peers Undervalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 16.8 | 22.0 | -24% below |
| P/B Ratio | -13.2 | 4.0 | Inline |
| Dividend Yield | 61.0% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a discount to sector peers — potential value opportunity.
Intrinsic Value (DCF) Overvalued
Intrinsic Value
398.84
vs
Market Price
507.48
Upside
-21.4%
| Margin of Safety | -27.2% |
| Stage 1 PV (5yr FCF) | 21,686,552,527 |
| Terminal Value PV | 61,627,839,232 |
| Total Enterprise Value | 83,314,391,759 |
Assumptions
| Base FCF | 5,038,487,029 |
| Growth Rate (5yr) | 3.6% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
37.97%
Full Kelly
18.99%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 58/100. Estimated win rate 57%, avg win 8.5%, avg loss 3.8%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary BUY
3
Bullish Signals
2
Bearish Signals
68.56
RSI(14)
13.7876
MACD
Relative Strength (RS) IMPROVING
62
/ 99
RS Rating
O'Neil filter: <80
| RS vs SPY | ↑ RISING (+28.0% vs SPY 3M) |
| RS vs Sector | OUTPERFORMING (Healthcare) |
| RS New High | ✓ RS at 3-month high Institutional accumulation signal |
| Sector Outperformance | +10.0% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
IMPROVING:
Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 68.56 | NEUTRAL |
| Macd | 13.7876 | BULLISH |
| Ma Cross | 441.9 / 443.45 | DEATH CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | UPPER BAND | |
| Volume | 1.15x | NORMAL |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 556.52 |
| Bollinger Upper | 499.48 |
| SMA(200) | 443.45 |
| SMA(50) | 441.9 |
| SMA(20) | 468.15 |
| Current Price | 507.48 |
| Bollinger Lower | 436.83 |
| 52-Week Low | 353.99 |
| ATR(14) | 17.43 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
MARKUP
Confidence
47%
Buying Climax
Sign of Strength
Selling Climax
Acc: 2.0 |
Dist: 2.0 |
Markup: 3.5 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-10-30 | Normal | 0.78x | Normal bar — no special VSA pattern |
| 2026-11-02 | Normal | 0.96x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.69x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 2.39x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.15x | Normal bar — no special VSA pattern |
Ichimoku Cloud BULLISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 480.65 | Above Kijun |
| Kijun-sen (26) | 471.97 | Base line |
| Senkou A | 476.31 | Leading span A |
| Senkou B | 458.38 | Leading span B |
| Cloud | 458.38 – 476.31 | Bullish (Green) |
| Price vs Cloud | 507.48 | Above Cloud |
| Chikou Span | 423.39 | Bullish |
| Alignment Score | 4/4 | BULLISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BULLISH FADING
BB: 436.83 – 499.48 | KC: 442.84 – 493.47
Divergences (last 60 bars)
No significant divergences detected in the last 60 bars.
Anchored VWAP
VWAP: 424.34
Anchor: 2026-07-14 (52w Low)
ABOVE AVWAP
+19.6%
Heikin-Ashi Trend
WEAKLY BULLISH
Full data via /api/advanced/HCA
Valuation
| Metric | Value |
|---|---|
| Market Cap | 106.01B |
| P/E (TTM) | 16.83 |
| Forward P/E | N/A |
| P/B | -13.25 |
| EPS | 30.15 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 3.6% |
| Profit Margin | 8.6% |
| ROE | N/A |
| Debt/Equity | N/A |
| Current Ratio | 0.82 |
| Dividend Yield | 61.0% |
| Payout Ratio | N/A |
| Beta | 1.10 |
Trading Data
507.48
Open
507.48
Day High
507.48
Day Low
1.66M
Volume (1.2x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)